Tech Company Financing Transactions
Concerto HealthAI Funding Round
On 1/14/2020, Concerto HealthAI landed $150 million in Series B funding from Declaration Partners, AllianceBernstein and Maverick Capital.
Transaction Overview
Company Name
Announced On
1/14/2020
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series B
Investors
Proceeds Purpose
The Series B funding will support Concerto HealthAI's continued innovation in RWD and technology products and services for regulatory and non-regulatory applications, expansion into adjacent therapy areas, and commercial patient solutions.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
501 Boylston St.
Boston, MA 02116?
USA
Boston, MA 02116?
USA
Phone
Undisclosed
Website
Email Address
Overview
Concerto HealthAI is a global leader in real-world data, AI technology, and real-world evidence services for precision oncology and dedicated to engineering integrated data and technology solutions that help achieve the best possible outcomes for patients.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/14/2020: Locale Hospitality venture capital transaction
Next: 1/14/2020: SIMBA Chain venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs